CB
CLRB icon

Commerce Bank’s Cellectar Biosciences CLRB Stock Holding History

Commerce Bank’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-333
Closed -$3.15K – 1194
2025
Q1 		$3.15K Buy
+333
New +$3.02K ﹤0.01% 1174
2024
Q4 		– Sell
-467
Closed -$30K – 1188
2024
Q3 		$30K Hold
467
– – ﹤0.01% 1216
2024
Q2 		$35K Sell
467
-66
-12% -$6.33K ﹤0.01% 1191
2024
Q1 		$63.7K Buy
533
+133
+33% +$14.4K ﹤0.01% 1183
2023
Q4 		$33.2K Hold
400
– – ﹤0.01% 1174
2023
Q3 		$31.7K Buy
+400
New +$23.6K ﹤0.01% 1136
2022
Q3 		– Sell
-48
Closed -$6K – 1142
2022
Q2 		$6K Hold
48
– – ﹤0.01% 1142
2022
Q1 		$10K Hold
48
– – ﹤0.01% 1171
2021
Q4 		$9K Hold
48
– – ﹤0.01% 1176
2021
Q3 		$13K Buy
+48
New +$14.6K ﹤0.01% 1159

Other funds holding CLRB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
RCA
Riverview Capital Advisers Boston, Massachusetts $300M AUM 10.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank's CLRB Position: Q2 2025 in Review

Commerce Bank sold out of Cellectar Biosciences (CLRB) in Q2 2025, closing a stake of 333 shares — an estimated $3.15K sold.

Commerce Bank first reported a position in CLRB in Q3 2021 and held it in 10 quarters. The position peaked at $63.7K in Q1 2024. 19 funds tracked by Wall St. Rank hold CLRB as of Q2 2025.

  • Commerce Bank reported no remaining Cellectar Biosciences position as of Q2 2025 after selling out during the quarter.
  • Commerce Bank sold 333 Cellectar Biosciences shares in Q2 2025, an estimated $3.15K.
  • Commerce Bank first reported a position in Cellectar Biosciences in Q3 2021 and held it in 10 quarters.
  • Commerce Bank's Cellectar Biosciences position peaked at $63.7K in Q1 2024.
  • 19 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q2 2025.

Based on Commerce Bank's 13F filing for Q2 2025, filed 7 Aug 2025.